WASHINGTON, D.C., September 22, 2021 – Cozen O’Connor is honored to announce the addition of distinguished patent counselor Todd B. Buck, Ph.D. to the Intellectual Property and Business Law Practices in Washington, D.C. Buck brings an impressive resume with over two decades of experience in the life sciences intellectual property sector. Armed with a Ph.D. in pharmacology and toxicology, Buck’s career has spanned all facets of intellectual property law, making him one of the most well-rounded patent counselors practicing in the life sciences space. Buck has vast experience in counseling and strategic planning in complex intellectual property issues for startups, small, large, and multi-billion-dollar global companies in the pharmaceutical, medical device, and biotechnology industries.
Buck began his career in IP litigation and used these perspectives to hone his skills in patent procurement. Buck has been lead counsel in state trade secret misappropriation, federal district court appeals of USPTO board decisions, as well we USPTO inter partes disputes, including lead counsel in interferences representing Nobel laureates in the seminal work on RNAi and gene silencing technology. Buck joins as a member, and his addition marks the continued growth of Cozen O’Connor’s Intellectual Property Department, as well as the overall growth of the Washington, D.C., office during the past 12 months.
“We are thrilled to welcome Todd to the Washington, D.C. office,” said Jonathan M. Grossman, office managing partner. “With almost two decades of experience in the complex world of developing and defending patent portfolios surrounding key platform technologies, I have no doubt that Todd will be an asset to Cozen O’Connor and our clients.”
Buck’s experience allows him to serve as de facto chief IP counsel for many of his clients, including those pursuing molecular diagnostics, cell therapy, pharmaceutical manufacturing, and AI-based RNA products. His background and experience in negotiating and counseling clients in numerous transactions make him a key asset to the Corporate and Health and Life Sciences Practices, where he will join an established team of outstanding attorneys in working with the firm’s life sciences clients in all facets of their corporate and intellectual property matters.
“Bringing Todd over to the Intellectual Property Department is an incredible victory for Cozen O’Connor as well as our clients. The nexus of AI and life sciences has hardly been scratched and having a distinguished adviser on board who carries with him a level of experience and depth that is unmatched is very exciting indeed. We anticipate significant cross-practice efforts as his background will make him a key resource for clients focused on the life sciences and emerging biotechnology spaces, and his ability to maximize the strength of our life sciences clients’ IP estates will invariably create and add value,” said Kerry B. McTigue, co-chair of the firm’s Intellectual Property Department.
“This is a tremendous opportunity for me to work with a well-respected team and be able to surround myself with colleagues who have significant experience in representing established and emerging growth companies,” Buck said. “I believe my experience and background in some of the most cutting-edge life-sciences technologies will be beneficial for Cozen O’Connor clients, and I am thrilled to join the firm.”
Buck earned his J.D. from the George Washington School of Law, his Ph.D. in pharmacology and toxicology from the University of Georgia, and his B.S. in biology from Oglethorpe University.
About Cozen O’Connor
Established in 1970, Cozen O’Connor has over 825 attorneys who help clients manage risk and make better business decisions. The firm counsels clients on their most sophisticated legal matters in all areas of the law, including litigation, corporate, and regulatory law. Representing a broad array of leading global corporations and middle-market companies, Cozen O’Connor serves its clients’ needs through 31 offices across two continents.